Mendelian disorders testing market: Rising demand for genetic testing is projected to boost the market at a CAGR of 6.5% during the forecast period 2017-2023

Pune, India, February 2018 /MRFR Press Release/- Market Research Future has a half-cooked research report on the global mendelian disorders testing the market.

Market Highlights:

Genetic testing involves various medical test that helps us identify changes in chromosomes, genes, or proteins. The genetic tests can confirm or rule out a suspected genetic condition, and it can help determine a person’s probability of developing a genetic disorder or passing on the same to next generation. Currently, there are more than 1,000 genetic tests in use, and more are being developed. Although genetic testing can provide important information for diagnosing, treating and preventing illness, there are some limitations to it.

There has been tremendous growth in the prevalence of the genetic disorders which may be due to various reasons such as geographical and environmental changes, change in the food habits, pollution, exposure to the harmful radiations or chemicals among other. These genetic disorders affect the person’s life. Moreover, the important and disturbing fact of the genetic disorders is that they are passed on from one generation to the next. Various genetic tests are being developed to diagnose these genetic diseases and counter them accordingly. Currently, there are more than 2000 genetic tests available in the market.

Rising awareness of genetic disorders drives the global mendelian disorders testing market among the population. The advanced technological platforms and improved genomic tools are the key factors driving the growth of the global mendelian disorders testing market during the forecast period. The restraining factors include lack of skilled professionals and lack of knowledge.

Access Report Deatails @ https://www.marketresearchfuture.com/reports/mendelian-disorders-testing-market-5500

Regional Analysis

The global Mendelian disorders testing market consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East.

The Americas region dominates the global monogenetic disorders testing market due to a high degree of intelligence and awareness regarding the monogenic disorders testing procedures. The companies are focused on introducing the procedures with innovative technology.

The European market holds the second largest share of the global mendelian disorders testing market owing to the increasing investment by the hospital facilities and government for better healthcare is expected to drive the market.

The Asia Pacific is expected to be the fastest growing region and is anticipated to compete with the American market over the forecasted period. Companies are collaborating with manufacturers and marketing firms, thus facilitating the development of better products available at lower prices. The incidence of cystic fibrosis varies across the globe. Although it is severely underdiagnosed in Asia, existing evidence indicates that the prevalence of cystic fibrosis is rare.

For instance, in Iran, it is estimated that about 8,000 pregnancies are at risk each year. In some endemic countries in the Mediterranean region, long-established control programs have achieved 80-100% prevention of newly affected births.

Segmentation

The global mendelian disorders testing market is segmented on the basis of test type, disorder type, and end user.

On the basis of the test type, the global mendelian disorders testing market is segmented into carrier testing, diagnostic testing, newborn screening, predictive & pre-symptomatic testing, prenatal testing, and others

On the basis of the disorder type, the global mendelian disorders testing market is segmented into cystic fibrosis, sickle cell anemia, severe combined immunodeficiency (SCID), Tay-Sachs disorder, polycystic kidney disorder, Gaucher's disease, Huntington's disease, neurofibromatosis, thalassemia, familial hypercholesterolemia, and others

On the basis of the end user, the global mendelian disorders testing market is segmented into hospitals, ambulatory surgical centers (ASCs), and specialized clinics.

Key Players:

Some of key the players in the global mendelian disorders testing market are Celera Group (U.S.), Abbott Laboratories (U.S.), ELITechGroup (France), Quest Diagnostics (U.S.), AutoGenomics (U.S.), PerkinElmer Inc. (U.S.), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Applied Biosystems Inc. (U.S.),  Transgenomic Inc. (U.S.),  and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com